Literature DB >> 15234149

Ocular manifestations of Niemann-Pick disease type B.

Margaret M McGovern1, Melissa P Wasserstein, Alan Aron, Robert J Desnick, Edward H Schuchman, Scott E Brodie.   

Abstract

PURPOSE: To investigate the ocular manifestations in Niemann-Pick disease type B (NPD-B).
DESIGN: Observational case series. PARTICIPANTS: Forty-five patients (23 male and 22 female) with NPD-B from 37 unrelated families.
METHODS: Serial clinical evaluations were carried out over a 2- to 14-year period, including a complete physical examination, neurologic assessment, and ophthalmologic examination. Genotyping of the specific mutations in the acid sphingomyelinase (ASM) gene was performed when possible for genotype-phenotype correlations. MAIN OUTCOME MEASURES: Fundus photographs to evaluate the retina, ASM genotype, and neurologic examination findings.
RESULTS: Ophthalmoscopic examination revealed retinal stigmata in 15 of 45 patients, 3 with macular halos and 12 with cherry red maculae. Neurologic examinations did not reveal any evidence of neurodegeneration, and there was no consistent relationship between retinal findings and genotype.
CONCLUSIONS: The presence of macular halos and/or cherry red maculae is not an absolute predictor of neurodegeneration, but should prompt a thorough evaluation to determine the underlying etiology and the precise diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234149     DOI: 10.1016/j.ophtha.2003.10.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Diagnostic and predictive methods for a Niemann-Pick disease type B patient with ocular involvement.

Authors:  Cinoo Kim; Jinho Jeong; Hyeong Gon Yu
Journal:  J Inherit Metab Dis       Date:  2010-06-29       Impact factor: 4.982

Review 2.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

Review 3.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

Review 4.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

Review 5.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

6.  A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B.

Authors:  Margaret M McGovern; Melissa P Wasserstein; Roberto Giugliani; Bruno Bembi; Marie T Vanier; Eugen Mengel; Scott E Brodie; David Mendelson; Gwen Skloot; Robert J Desnick; Noriko Kuriyama; Gerald F Cox
Journal:  Pediatrics       Date:  2008-07-14       Impact factor: 7.124

Review 7.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

8.  Inner macular hyperreflectivity demonstrated by optical coherence tomography in niemann-pick disease.

Authors:  Danielle S Rudich; Christine A Curcio; Melissa Wasserstein; Scott E Brodie
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

9.  Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration.

Authors:  Bill X Wu; Jie Fan; Nicholas P Boyer; Russell W Jenkins; Yiannis Koutalos; Yusuf A Hannun; Craig E Crosson
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 10.  Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).

Authors:  Margaret M McGovern; Ruzan Avetisyan; Bernd-Jan Sanson; Olivier Lidove
Journal:  Orphanet J Rare Dis       Date:  2017-02-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.